Lipoquin (liposomal ciprofloxacin SR) / Aradigm 
Welcome,         Profile    Billing    Logout  
 8 Diseases   1 Trial   1 Trial   5 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lipoquin (liposomal ciprofloxacin SR) / Aradigm
ACTRN12609000578202: An International, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Mixture Formulation Consisting of Liposomal and Free Ciprofloxacin for Inhalation Compared with Placebo for Inhalation in the Management of Pseudomonas aeruginosa in Patients with Non-Cystic Fibrosis Bronchiectasis with Chronic Lung Infections.

Recruiting
2
40
 
Aradigm Corporation, Aradigm Corporation
Non cystic fibrosis (CF) bronchiectasis
 
 

Download Options